GroundRules
← Search the law
Federal regulations · Through 2026-08-25 · Newer source version available

21 CFR 864.7040: Adenosine triphosphate release assay.

Read at publisher ↗
Where this section sits in the code
  1. Title 21—Food and Drugs
  2. CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES
  3. SUBCHAPTER H—MEDICAL DEVICES
  4. PART 864—HEMATOLOGY AND PATHOLOGY DEVICES
  5. Subpart H—Hematology Kits and Packages

(a) Identification. An adenosine triphosphate release assay is a device that measures the release of adenosine triphosphate (ATP) from platelets following aggregation. This measurement is made on platelet-rich plasma using a photometer and a luminescent firefly extract. Simultaneous measurements of platelet aggregation and ATP release are used to evaluate platelet function disorders.

(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

Collected 2026-08-27T02:24:47Z. Source file · JSON

Browse this collection